Morgan Stanley »

Alaunos Therapeutics Inc - US shares owned by Morgan Stanley

Quarter-by-quarter ownership of Alaunos Therapeutics Inc - US shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Alaunos Therapeutics Inc - US

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics Inc - US held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics Inc - US by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $15k 15k 1.00
2024-03-31 $31k 17k 1.81

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Morgan Stanley

Top funds holding Alaunos Therapeutics Inc - US

MSDC Management
Vanguard Group
BlackRock
Geode Capital Management
Citadel Advisors
State Street Corporation
Commerce Bank N A
Allred Capital Management
PFG Investments
Morgan Stanley
Atlantic Trust
Dimensional Fund Advisors
Group One Trading
Sanctuary Advisors
Atria Wealth Solutions

View all funds holding Alaunos Therapeutics Inc - US